Source-grounded facts extracted from Covista Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Covista Inc. reported fiscal year 2026 results: revenue $1,930 million to $1,945 million, EPS $7.95 to $8.15. Guidance raised.
“Revenue of $1,930 million to $1,945 million, or approximately 8% to 9% growth year-over-year, and from a previous range of $1,900 million to $1,940 million ● Adjusted earnings per share of $7.95 to $8.15, or approximately 19% to 22% growth year-over-year, and from a previous range of $7.80 to $8.00”
Covista Inc. reported third quarter fiscal year 2026 (ended March 31, 2026) results: revenue $487.0 million, net income $41.6 million, EPS $1.20. Guidance raised.
“Revenue of $487.0 million increased 4.5% compared with the prior year ● Operating income of $91.3 million, compared with $90.5 million in the prior year; adjusted operating income of $102.2 million, compared with $105.4 million in the prior year ● Net income of $41.6 million, compared with $60.8 million in the prior year; adjusted net income of $69.0 million, compared with $73.3 million in the prior year ● Diluted earnings per share of $1.20, compared with $1.59 in the prior year; adjusted earnings per share of $1.98, compared with $1.92 in the prior year”
Covista Inc. incurred term loan of $510 million with Morgan Stanley Senior Funding, Inc. at Term SOFR plus 2.25% (subject to a SOFR floor of 0.75%) or an alternate base rat maturing March 2, 2033.
“in order to, among other things, incur new term loans thereunder (consisting of refinancing term loans and incremental term loans) in an aggregate original principal amount of $510 million (collectively, the “2026 Term Loans”), which 2026 Term Loans mature on March 2, 2033.”
Covista Inc. terminated Indenture with U.S. Bank National Association, as trustee and notes collateral agent valued at approximately $404,950,000 (effective 2026-03-02).
“Upon deposit of the Redemption Payment with the Trustee on the Redemption Date, the Indenture was fully satisfied and discharged in accordance with its terms and the Company and the subsidiary guarantors party thereto have no further obligations under the Indenture.”
Covista Inc. amended Amendment No. 5 to Credit Agreement and Incremental Assumption Agreement with Morgan Stanley Senior Funding, Inc., as administrative agent, and the lender party valued at $510 million (effective 2026-03-02).
“On March 2, 2026, Covista Inc. (formerly known as Adtalem Global Education Inc.) ("Covista", the "Company", or "we") entered into Amendment No. 5 to Credit Agreement and Incremental Assumption Agreement, dated as of March 2, 2026 (the "Amendment"), by and among the Company, as borrower, the guarantors party thereto, the lender party thereto and Morgan Stanley Senior Funding, Inc. ("MSSF"), as administrative agent”
Covista Inc.: Amended bylaws to reflect new corporate name and update registered agent (effective 2026-02-05).
“In connection with our name change, our board of directors amended our by-laws to reflect the corporate name Covista Inc., also effective as of February 5, 2026.”
Covista Inc.: Changed corporate name from Adtalem Global Education Inc. to Covista Inc (effective 2026-02-05).
“On February 5, 2026, Covista Inc. (“Covista,” the “Company,” or “we”), previously known as Adtalem Global Education Inc., filed with the Secretary of State of Delaware a Certificate of Amendment (the “Amendment”) to our Amended and Restated Certificate of Incorporation to change our corporate name from Adtalem Global Education Inc. to Covista Inc., effective February 5, 2026.”
Covista Inc. incurred revolving credit of $100.0 million increase resulting in aggregate outstanding commitments of $500.0 million under the revolving facility with Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent, and the lenders and issuing banks party thereto at SOFR plus an applicable margin ranging from 2.25% to 3.00% or alternate base rat maturing August 6, 2030.
“On August 6, 2025, Adtalem Global Education Inc. (“Adtalem”) entered into Amendment No. 4 to Credit Agreement and Incremental Assumption Agreement (the “Amendment”), by and among Adtalem, the other guarantors party thereto, the lenders and issuing banks party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent, which amended our Credit Agreement, dated as of August 12, 2021 (as amended, amended and restated, supplemented or otherwise modified from time to time), in order to, among other things, (i) increase available commitments under our revolving facility by $100.0 million (resulting in aggregate outstanding commitments of $500.0 million under the revolving facility after giving effect to the Amendment), (ii) extend the maturity and commitment termination date of our revolving facility to August 6, 2030 (subject to an earlier springing maturity if we do not refinance, redeem or repay certain other material indebtedness on the date that is 91”
Michael W. Malafronte changed role as Lead Independent Director at Covista Inc..
“Mr. Malafronte will continue to serve on the Board as Lead Independent Director, Chair of the Compensation Committee, and a member of the Academic Quality Committee.”
Stephen W. Beard changed role as Chairman of the Board at Covista Inc..
“On November 13, 2024, the Board of Directors (the “Board”) of Adtalem Global Education Inc. (“Adtalem” or “the Company”) unanimously elected Stephen W. Beard, Adtalem’s President and Chief Executive Officer, as Chairman of the Board effective immediately.”
Covista Inc. updated its fiscal year 2024 guidance (raised).
“Adtalem guidance for fiscal year 2024, raises revenue guidance to a range of $1,560 million to $1,580 million from $1,520 million to $1,560 million, and raises adjusted earnings per share to be in the range of $4.80 to $5.00 from $4.55 to $4.75.”
Covista Inc. reported fiscal 2024 third quarter results: revenue $412.7 million, net income $36.8 million, EPS $0.93. Guidance raised.
“Guidance Raised Revenue up 11.8% YoY Total enrollment up 7.8% YoY Diluted earnings per share $0.93; Adjusted EPS $1.50, growth of 32.7% YoY Third Quarter Highlights ● Revenue $412.7 million, up 11.8% year-over-year ● Total student enrollment 85,809, up 7.8% year-over-year ● Chamberlain University fifth straight quarter of total enrollment growth, up 9.0%”
Dr. John Danaher departed as President, Medical & Veterinary at Covista Inc..
“reporting that Dr. John Danaher President, Medical & Veterinary was leaving Adtalem effective September 15, 2023.”
Covista Inc. reported second quarter fiscal 2024 (ended Dec. 31, 2023) results: revenue $393.2 million, net income $39.9 million, EPS $0.98 per diluted share. Guidance raised.
“Guidance Raised Revenue up 8.4% YoY Total enrollment up 6.2% YoY Diluted earnings per share $0.98; Adjusted EPS $1.23, growth of 5.1% YoY Second quarter highlights ● Revenue $393.2 million, up 8.4% year-over-year ● Total student enrollment 81,772, up 6.2% year-over-year ● Chamberlain University fourth straight quarter of total enrollment growth, up 6.6%”
Betty Vandenbosch was appointed as independent director at Covista Inc..
“The Adtalem Board of Directors (the “Board”) has appointed Dr. Betty Vandenbosch as an independent member of Adtalem’s Board effective January 8, 2024”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.